申请人:Italfarmaco, S.A.
公开号:EP1602644A1
公开(公告)日:2005-12-07
A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10R11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH-CO-R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH-CO-R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.
一种具有化学式(I)的萘磺酸或喹啉磺酸,其中A为N或CR8配方基团,其中R8为H、OH、NR10R11,独立地,其中R10和R11分别代表H或C1-C6烷基或配方NH-CO-R12的基团,其中R12为C1-C6烷基或C6-C10芳基;R1和R2独立地代表H或SO3R9,其中R9为H、铵或碱金属或碱土金属的阳离子;R3为H或OH;R4、R5、R6和R7独立地代表H、NR10R11或NH-CO-R12基团;条件是(i)R1或R2中至少有一个为SO3R9,(ii)R4、R5、R6或R7中至少有一个为NR10R11或NH-CO-R12基团,或它们的药用可接受盐;以及药用可接受的赋形剂。